Revvity Inc. (NYSE:RVTY) Receives Consensus Rating of “Hold” from Brokerages

Revvity Inc. (NYSE:RVTY) has been assigned an average rating of “Hold” from the fourteen research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $115.25.

Several research analysts recently commented on the company. Bank of America downgraded Revvity from a “buy” rating to a “neutral” rating and set a $110.00 price objective for the company. in a research note on Monday, December 15th. Weiss Ratings reiterated a “sell (d)” rating on shares of Revvity in a research report on Monday. The Goldman Sachs Group assumed coverage on shares of Revvity in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $105.00 price target on the stock. Wells Fargo & Company upped their price objective on shares of Revvity from $102.00 to $107.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. Finally, Evercore ISI reissued an “outperform” rating and issued a $108.00 target price on shares of Revvity in a research note on Monday, October 27th.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Tudor Investment Corp ET AL purchased a new stake in shares of Revvity in the third quarter valued at about $15,128,000. Swiss Life Asset Management Ltd boosted its holdings in Revvity by 19.7% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 29,099 shares of the company’s stock valued at $2,551,000 after purchasing an additional 4,795 shares during the last quarter. CIBC Bancorp USA Inc. acquired a new position in Revvity in the 3rd quarter valued at about $1,409,000. Danske Bank A S purchased a new stake in shares of Revvity in the 3rd quarter valued at approximately $3,430,000. Finally, Dark Forest Capital Management LP acquired a new stake in shares of Revvity during the 3rd quarter worth approximately $877,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Trading Up 0.4%

RVTY stock opened at $97.51 on Wednesday. Revvity has a 12-month low of $81.36 and a 12-month high of $128.29. The business’s 50-day moving average is $97.24 and its 200 day moving average is $93.74. The company has a current ratio of 1.75, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. The stock has a market cap of $11.06 billion, a price-to-earnings ratio of 49.00, a PEG ratio of 3.21 and a beta of 1.06.

Revvity (NYSE:RVTY) last announced its earnings results on Monday, October 27th. The company reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.04. The business had revenue of $698.95 million during the quarter, compared to analysts’ expectations of $699.75 million. Revvity had a return on equity of 7.52% and a net margin of 8.44%.The business’s revenue was up 2.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.28 earnings per share. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS. On average, sell-side analysts anticipate that Revvity will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 6th. Investors of record on Friday, January 16th will be given a dividend of $0.07 per share. The ex-dividend date is Friday, January 16th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s dividend payout ratio (DPR) is presently 14.07%.

Revvity declared that its board has authorized a share buyback program on Monday, October 27th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 8.7% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its stock is undervalued.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.